PBRM1 and exocrine pancreatic carcinoma: At the 2-week time point, control (KPF) animals developed well-differentiated PDACs, whereas Pbrm1-null mice exhibited significantly more poorly differentiated PDACs or undifferentiated carcinomas of the pancreas than control mice (Figure 5, C–E).